About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Licencing Agreement Update

September 10, 2018

Click here to read more

Post navigation

Phosphagenics Receives Arbitration Update from SIAC

Phosphagenics Receives Further Arbitration Process Update

Related Posts

AGM Chairman and CEO Addresses

May 31, 2017

Phosphagenics Announces Results of TPM Oxycodone Phase 2a Trial

January 29, 2016

Phosphagenics and Mylan Agree Settlement

December 19, 2018

Recent Posts

First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024
Avecho’s Phase III Clinical Trial for Insomnia Commences
March 26, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.